Skip to content

Clinical trials

Phase 3 Thrombocythemia, Essential trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Phase: Phase 3 Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20051
20071
20082
20091
20103
20111
20121
20131
20142
20161
20201
20222
20232
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting5
Recruiting3
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AOP Orphan Pharmaceuticals AG4
Merck Sharp & Dohme LLC3
Alliance for Clinical Trials in Oncology2
CTI BioPharma2
Memorial Sloan Kettering Cancer Center2
PharmaEssentia2
Shire2
Assistance Publique - Hôpitaux de Paris1
Case Comprehensive Cancer Center1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential29
Polycythemia Vera17
Primary Myelofibrosis16
Myeloproliferative Disorders13
Blast Crisis11
Burkitt Lymphoma11
Hodgkin Disease11
Immunoblastic Lymphadenopathy11
Immunoglobulin Light-chain Amyloidosis11
Leukemia, Hairy Cell11

Trials

Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.